IBDEI0A8 ; ; 09-AUG-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 12, 2016
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,12966,0)
 ;;=E13.9^^43^616^22
 ;;^UTILITY(U,$J,358.3,12966,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12966,1,3,0)
 ;;=3^Diabetes Mellitus (Secondary) w/o Complications NEC
 ;;^UTILITY(U,$J,358.3,12966,1,4,0)
 ;;=4^E13.9
 ;;^UTILITY(U,$J,358.3,12966,2)
 ;;=^5002704
 ;;^UTILITY(U,$J,358.3,12967,0)
 ;;=E16.2^^43^616^29
 ;;^UTILITY(U,$J,358.3,12967,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12967,1,3,0)
 ;;=3^Hypoglycemia,Unspec
 ;;^UTILITY(U,$J,358.3,12967,1,4,0)
 ;;=4^E16.2
 ;;^UTILITY(U,$J,358.3,12967,2)
 ;;=^5002708
 ;;^UTILITY(U,$J,358.3,12968,0)
 ;;=E20.0^^43^616^34
 ;;^UTILITY(U,$J,358.3,12968,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12968,1,3,0)
 ;;=3^Idiopathic Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,12968,1,4,0)
 ;;=4^E20.0
 ;;^UTILITY(U,$J,358.3,12968,2)
 ;;=^5002712
 ;;^UTILITY(U,$J,358.3,12969,0)
 ;;=E20.9^^43^616^30
 ;;^UTILITY(U,$J,358.3,12969,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12969,1,3,0)
 ;;=3^Hypoparathyroidism,Unspec
 ;;^UTILITY(U,$J,358.3,12969,1,4,0)
 ;;=4^E20.9
 ;;^UTILITY(U,$J,358.3,12969,2)
 ;;=^5002714
 ;;^UTILITY(U,$J,358.3,12970,0)
 ;;=E23.0^^43^616^31
 ;;^UTILITY(U,$J,358.3,12970,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12970,1,3,0)
 ;;=3^Hypopituitarism
 ;;^UTILITY(U,$J,358.3,12970,1,4,0)
 ;;=4^E23.0
 ;;^UTILITY(U,$J,358.3,12970,2)
 ;;=^60685
 ;;^UTILITY(U,$J,358.3,12971,0)
 ;;=E27.1^^43^616^51
 ;;^UTILITY(U,$J,358.3,12971,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12971,1,3,0)
 ;;=3^Primary Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,12971,1,4,0)
 ;;=4^E27.1
 ;;^UTILITY(U,$J,358.3,12971,2)
 ;;=^5002740
 ;;^UTILITY(U,$J,358.3,12972,0)
 ;;=E27.2^^43^616^1
 ;;^UTILITY(U,$J,358.3,12972,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12972,1,3,0)
 ;;=3^Addisonian Crisis
 ;;^UTILITY(U,$J,358.3,12972,1,4,0)
 ;;=4^E27.2
 ;;^UTILITY(U,$J,358.3,12972,2)
 ;;=^263725
 ;;^UTILITY(U,$J,358.3,12973,0)
 ;;=E27.3^^43^616^23
 ;;^UTILITY(U,$J,358.3,12973,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12973,1,3,0)
 ;;=3^Drug-induced Adrenocortical Insufficiency
 ;;^UTILITY(U,$J,358.3,12973,1,4,0)
 ;;=4^E27.3
 ;;^UTILITY(U,$J,358.3,12973,2)
 ;;=^5002741
 ;;^UTILITY(U,$J,358.3,12974,0)
 ;;=E29.1^^43^616^52
 ;;^UTILITY(U,$J,358.3,12974,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12974,1,3,0)
 ;;=3^Testicular Hypofunction
 ;;^UTILITY(U,$J,358.3,12974,1,4,0)
 ;;=4^E29.1
 ;;^UTILITY(U,$J,358.3,12974,2)
 ;;=^5002754
 ;;^UTILITY(U,$J,358.3,12975,0)
 ;;=E55.9^^43^616^59
 ;;^UTILITY(U,$J,358.3,12975,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12975,1,3,0)
 ;;=3^Vitamin D Deficiency,Unspec
 ;;^UTILITY(U,$J,358.3,12975,1,4,0)
 ;;=4^E55.9
 ;;^UTILITY(U,$J,358.3,12975,2)
 ;;=^5002799
 ;;^UTILITY(U,$J,358.3,12976,0)
 ;;=E66.01^^43^616^38
 ;;^UTILITY(U,$J,358.3,12976,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12976,1,3,0)
 ;;=3^Morbid Obesity
 ;;^UTILITY(U,$J,358.3,12976,1,4,0)
 ;;=4^E66.01
 ;;^UTILITY(U,$J,358.3,12976,2)
 ;;=^5002826
 ;;^UTILITY(U,$J,358.3,12977,0)
 ;;=E66.8^^43^616^42
 ;;^UTILITY(U,$J,358.3,12977,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12977,1,3,0)
 ;;=3^Obesity NEC
 ;;^UTILITY(U,$J,358.3,12977,1,4,0)
 ;;=4^E66.8
 ;;^UTILITY(U,$J,358.3,12977,2)
 ;;=^5002831
 ;;^UTILITY(U,$J,358.3,12978,0)
 ;;=E66.9^^43^616^43
 ;;^UTILITY(U,$J,358.3,12978,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12978,1,3,0)
 ;;=3^Obesity,Unspec
 ;;^UTILITY(U,$J,358.3,12978,1,4,0)
 ;;=4^E66.9
 ;;^UTILITY(U,$J,358.3,12978,2)
 ;;=^5002832
 ;;^UTILITY(U,$J,358.3,12979,0)
 ;;=E74.39^^43^616^35
 ;;^UTILITY(U,$J,358.3,12979,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12979,1,3,0)
 ;;=3^Intestinal Carbohydrate Absorption Disorder NEC
 ;;^UTILITY(U,$J,358.3,12979,1,4,0)
 ;;=4^E74.39
 ;;^UTILITY(U,$J,358.3,12979,2)
 ;;=^5002928
 ;;^UTILITY(U,$J,358.3,12980,0)
 ;;=E83.30^^43^616^46
 ;;^UTILITY(U,$J,358.3,12980,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12980,1,3,0)
 ;;=3^Phosphorus Metabolism Disorder,Unspec
 ;;^UTILITY(U,$J,358.3,12980,1,4,0)
 ;;=4^E83.30
 ;;^UTILITY(U,$J,358.3,12980,2)
 ;;=^5002997
 ;;^UTILITY(U,$J,358.3,12981,0)
 ;;=E83.51^^43^616^28
 ;;^UTILITY(U,$J,358.3,12981,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12981,1,3,0)
 ;;=3^Hypocalcemia
 ;;^UTILITY(U,$J,358.3,12981,1,4,0)
 ;;=4^E83.51
 ;;^UTILITY(U,$J,358.3,12981,2)
 ;;=^60542
 ;;^UTILITY(U,$J,358.3,12982,0)
 ;;=E83.52^^43^616^26
 ;;^UTILITY(U,$J,358.3,12982,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12982,1,3,0)
 ;;=3^Hypercalcemia
 ;;^UTILITY(U,$J,358.3,12982,1,4,0)
 ;;=4^E83.52
 ;;^UTILITY(U,$J,358.3,12982,2)
 ;;=^59932
 ;;^UTILITY(U,$J,358.3,12983,0)
 ;;=E87.5^^43^616^27
 ;;^UTILITY(U,$J,358.3,12983,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12983,1,3,0)
 ;;=3^Hyperkalemia
 ;;^UTILITY(U,$J,358.3,12983,1,4,0)
 ;;=4^E87.5
 ;;^UTILITY(U,$J,358.3,12983,2)
 ;;=^60041
 ;;^UTILITY(U,$J,358.3,12984,0)
 ;;=E89.2^^43^616^48
 ;;^UTILITY(U,$J,358.3,12984,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12984,1,3,0)
 ;;=3^PostProcedural Hypoparathyroidism
 ;;^UTILITY(U,$J,358.3,12984,1,4,0)
 ;;=4^E89.2
 ;;^UTILITY(U,$J,358.3,12984,2)
 ;;=^5003037
 ;;^UTILITY(U,$J,358.3,12985,0)
 ;;=E89.6^^43^616^47
 ;;^UTILITY(U,$J,358.3,12985,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12985,1,3,0)
 ;;=3^PostProcedural Adrenocortical Hypofunction
 ;;^UTILITY(U,$J,358.3,12985,1,4,0)
 ;;=4^E89.6
 ;;^UTILITY(U,$J,358.3,12985,2)
 ;;=^5003042
 ;;^UTILITY(U,$J,358.3,12986,0)
 ;;=L68.0^^43^616^25
 ;;^UTILITY(U,$J,358.3,12986,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12986,1,3,0)
 ;;=3^Hirsutism
 ;;^UTILITY(U,$J,358.3,12986,1,4,0)
 ;;=4^L68.0
 ;;^UTILITY(U,$J,358.3,12986,2)
 ;;=^5009262
 ;;^UTILITY(U,$J,358.3,12987,0)
 ;;=M80.00XA^^43^616^2
 ;;^UTILITY(U,$J,358.3,12987,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12987,1,3,0)
 ;;=3^Age-Related Osteoporosis w/ Fx,Unspec Site,Init Encntr
 ;;^UTILITY(U,$J,358.3,12987,1,4,0)
 ;;=4^M80.00XA
 ;;^UTILITY(U,$J,358.3,12987,2)
 ;;=^5013363
 ;;^UTILITY(U,$J,358.3,12988,0)
 ;;=M81.0^^43^616^3
 ;;^UTILITY(U,$J,358.3,12988,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12988,1,3,0)
 ;;=3^Age-Related Osteoporosis w/o Fx
 ;;^UTILITY(U,$J,358.3,12988,1,4,0)
 ;;=4^M81.0
 ;;^UTILITY(U,$J,358.3,12988,2)
 ;;=^5013555
 ;;^UTILITY(U,$J,358.3,12989,0)
 ;;=M85.80^^43^616^44
 ;;^UTILITY(U,$J,358.3,12989,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12989,1,3,0)
 ;;=3^Osteopenia,Unspec Site
 ;;^UTILITY(U,$J,358.3,12989,1,4,0)
 ;;=4^M85.80
 ;;^UTILITY(U,$J,358.3,12989,2)
 ;;=^5014473
 ;;^UTILITY(U,$J,358.3,12990,0)
 ;;=N62.^^43^616^24
 ;;^UTILITY(U,$J,358.3,12990,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12990,1,3,0)
 ;;=3^Gynecomastia
 ;;^UTILITY(U,$J,358.3,12990,1,4,0)
 ;;=4^N62.
 ;;^UTILITY(U,$J,358.3,12990,2)
 ;;=^5015790
 ;;^UTILITY(U,$J,358.3,12991,0)
 ;;=E10.43^^43^616^6
 ;;^UTILITY(U,$J,358.3,12991,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12991,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Autonomic Polyneuropathy
 ;;^UTILITY(U,$J,358.3,12991,1,4,0)
 ;;=4^E10.43
 ;;^UTILITY(U,$J,358.3,12991,2)
 ;;=^5002607
 ;;^UTILITY(U,$J,358.3,12992,0)
 ;;=E10.59^^43^616^4
 ;;^UTILITY(U,$J,358.3,12992,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12992,1,3,0)
 ;;=3^DM Type 1 w/ Circulatory Complications
 ;;^UTILITY(U,$J,358.3,12992,1,4,0)
 ;;=4^E10.59
 ;;^UTILITY(U,$J,358.3,12992,2)
 ;;=^5002612
 ;;^UTILITY(U,$J,358.3,12993,0)
 ;;=E10.618^^43^616^5
 ;;^UTILITY(U,$J,358.3,12993,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12993,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Arthropathy
 ;;^UTILITY(U,$J,358.3,12993,1,4,0)
 ;;=4^E10.618
 ;;^UTILITY(U,$J,358.3,12993,2)
 ;;=^5002614
 ;;^UTILITY(U,$J,358.3,12994,0)
 ;;=E10.621^^43^616^7
 ;;^UTILITY(U,$J,358.3,12994,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12994,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Foot Ulcer
 ;;^UTILITY(U,$J,358.3,12994,1,4,0)
 ;;=4^E10.621
 ;;^UTILITY(U,$J,358.3,12994,2)
 ;;=^5002616
 ;;^UTILITY(U,$J,358.3,12995,0)
 ;;=E10.622^^43^616^11
 ;;^UTILITY(U,$J,358.3,12995,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12995,1,3,0)
 ;;=3^DM Type 1 w/ Skin Ulcer
 ;;^UTILITY(U,$J,358.3,12995,1,4,0)
 ;;=4^E10.622
 ;;^UTILITY(U,$J,358.3,12995,2)
 ;;=^5002617
 ;;^UTILITY(U,$J,358.3,12996,0)
 ;;=E10.65^^43^616^10
 ;;^UTILITY(U,$J,358.3,12996,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12996,1,3,0)
 ;;=3^DM Type 1 w/ Hyperglycermia
 ;;^UTILITY(U,$J,358.3,12996,1,4,0)
 ;;=4^E10.65
 ;;^UTILITY(U,$J,358.3,12996,2)
 ;;=^5002623
 ;;^UTILITY(U,$J,358.3,12997,0)
 ;;=E10.39^^43^616^9
 ;;^UTILITY(U,$J,358.3,12997,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12997,1,3,0)
 ;;=3^DM Type 1 w/ Diabetic Ophthalmic Complications NEC
 ;;^UTILITY(U,$J,358.3,12997,1,4,0)
 ;;=4^E10.39
 ;;^UTILITY(U,$J,358.3,12997,2)
 ;;=^5002603
 ;;^UTILITY(U,$J,358.3,12998,0)
 ;;=E66.3^^43^616^45
 ;;^UTILITY(U,$J,358.3,12998,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12998,1,3,0)
 ;;=3^Overweight
 ;;^UTILITY(U,$J,358.3,12998,1,4,0)
 ;;=4^E66.3
 ;;^UTILITY(U,$J,358.3,12998,2)
 ;;=^5002830
 ;;^UTILITY(U,$J,358.3,12999,0)
 ;;=E89.1^^43^616^49
 ;;^UTILITY(U,$J,358.3,12999,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,12999,1,3,0)
 ;;=3^Postprocedural Hypoinsulinemia
 ;;^UTILITY(U,$J,358.3,12999,1,4,0)
 ;;=4^E89.1
 ;;^UTILITY(U,$J,358.3,12999,2)
 ;;=^5003036
 ;;^UTILITY(U,$J,358.3,13000,0)
 ;;=H40.9^^43^617^9
 ;;^UTILITY(U,$J,358.3,13000,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13000,1,3,0)
 ;;=3^Glaucoma,Unspec
 ;;^UTILITY(U,$J,358.3,13000,1,4,0)
 ;;=4^H40.9
 ;;^UTILITY(U,$J,358.3,13000,2)
 ;;=^5005931
 ;;^UTILITY(U,$J,358.3,13001,0)
 ;;=H26.9^^43^617^5
 ;;^UTILITY(U,$J,358.3,13001,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13001,1,3,0)
 ;;=3^Cataract,Unspec
 ;;^UTILITY(U,$J,358.3,13001,1,4,0)
 ;;=4^H26.9
 ;;^UTILITY(U,$J,358.3,13001,2)
 ;;=^5005363
 ;;^UTILITY(U,$J,358.3,13002,0)
 ;;=H10.9^^43^617^8
 ;;^UTILITY(U,$J,358.3,13002,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,13002,1,3,0)
 ;;=3^Conjunctivitis,Unspec
